Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study

Journal of Medicine

Volumn 31, Issue 5-6, 2000, Pages 227-246

  Preuss, Harry G ^a,c   Wallerstedt, Dawn ^a   Talpur, Nadeem ^a   Tutuncuoglu, S Osman ^a   Echard, Bobby ^a   Myers, Adam ^a   Bui, Minh ^a   Bagchi, Debasis ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c Basic Science Bldg ^*  (United States)

Author keywords

Cholesterol; Grape seed proanthocyanidin extract; Hyper cholesterolemic patients; Niacin bound chromium; Oxidized LDL

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; CHROMIUM DERIVATIVE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; PLANT EXTRACT; PROANTHOCYANIDIN; TRIACYLGLYCEROL;

ANTIBODY TITER; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GRAPE; HUMAN; HYPERCHOLESTEROLEMIA; PLANT SEED; RANDOMIZED CONTROLLED TRIAL;

ANALYSIS OF VARIANCE; ANTHOCYANINS; ANTIOXIDANTS; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHROMIUM; DOUBLE-BLIND METHOD; FEMALE; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; NIACIN; NICOTINIC ACIDS; ORGANOMETALLIC COMPOUNDS; PILOT PROJECTS; PLACEBOS; PROANTHOCYANIDINS; ROSALES; TIME FACTORS; TRIGLYCERIDES;

EID: 0034448446     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Abraham, A.S., Brooks, B.A. and Eylath, U. (1992).: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metab. 41: 768-771.
2. American Heart Association. Research Facts - update. Facts about cardiovascular disease. American Heart Association, Dallas.
3. American Heart Association 1990 Heart and Stroke Facts. (1989).
4. Anderson, J.W. (1986).: Fiber and health: an overview. Amer. J. Gastro. 81: 892-897.
5. Anderson, J.W. and Tietyen-Clark, J. (1986).: Dietary fiber: hyperlipidemia, hypertension, and coronary heart disease. Amer. J. Gastro. 81: 907-919.
6. Bagchi, D., Bagchi, M., Stohs, S.J., Das, D.K., Ray, S.D., Kuszynski, C.A., Joshi, S.S. and Preuss, H.G. (2000). Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention. Toxicol. 148: 187-197.
7. Bagchi, M., Balmoori, J., Bagchi, D., Ray, S.D., Kuszynski, C. and Stohs, S.J. (1999a).: Smokeless tobacco, oxidative stress, apoptosis, and antioxidants in human oral keratinocytes. Free Rad. Biol. Med. 26: 992-1000.
8. Bagchi, D., Garg, A., Krohn, R.L., Bagchi, M., Tran, M.X. and Stohs, S.J. (1997).: Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Commun. Molec. Pathol. Pharmacol. 93: 179-189.
9. Bagchi, D., Garg, A., Krohn, R.L., Bagchi, M., Bagchi, D.J., Balmoori, J. and Stohs, S.J. (1998a).: Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. Gen. Pharmacol. 30: 771-776.
10. Bagchi, D., Kuszynski, C.A., Balmoori, J., Bagchi, M. and Stohs, S.J. (1998b).: Hydrogen peroxide-induced modulation of intracellular oxidized states in cultured macrophage J774A.1 and neuroactive PC-12 cells, and protection by a novel IH636 grape seed proanthocyanidin extract. Phytother. Res. 12: 568-571.
11. Bagchi, M., Milnes, M., Williams, C.B., Balmoori, J., Ye, X., Stohs, S.J. and Bagchi, D. (1999b).: Acute and chronic stress-induced oxidative gastrointestinal injury in rats, and the protective ability of a novel grape seed proanthocyanidin extract. Nutr. Res. 19: 1189-1199.
12. Bagchi, D., Ray, S.D., Patel, D. and Bagchi, M. (2001). Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. Drugs Exptl. Clin. Res. (in press).
13. Black, D.M., Bakker-Arkema, R.G. and Nawrocki, J.W. (1998).: An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor. Arch. Intern. Med. 158: 577-584.
14. Brown, W.V. (2000).: Cholesterol lowering in atherosclerosis. Amer. J. Cardiol. 86:29H-34H.
15. Bui, M.N., Sack, M.N., Moutsatsos, G., Lu, D.Y., Katz, P., McCown, R., Breall, J.A. and Rackley, C.E. (1996).: Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. Amer. Heart J. 131:663-667.
16. Cote, M., Shapcott, V., Pruzynski, V., Lemieux, E., Suarez De Lezo, J. and Delaye, J. (1985).: Hair chromium concentration and coronary artery disease in Canada, France, and Italy. Nutr. Res. Suppl I: 356-359.
17. Dunnett, C. (1955).: A multiple comparison procedure for comparing several treatments with control. J. Amer. Stat. Assoc. 50: 1096-1121.
18. Grundy, S.M. (1999).: Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Amer. J. Cardiol. 83: 25F-29F.
19. Grundy, S.M. (2000).: Cholesterol management in the era of managed care. Amer. J. Cardiol. 85: 3A-9A.
20. Guyton, J.R. and Capuzzi, D.M. (1998).: Treatment of hyperlipidemia with combined niacin-statin regimens. Amer. J. Cardiol. 82: 82U-86U.
21. Joshi, S.S., Kuszynski, C.A., Benner, E.J., Bagchi, M. and Bagchi, D. (1999).: Amelioration of cytotoxic effects of idarubicin and 4-hydroxyperoxycyclophosphamide on Chang liver cells by a novel grape seed proanthocyanidin extract. Antiox. Redox Signal. 1: 563-570.
22. Kandeswami, C. and Clouatre, D. (1998).: The health benefits of grape seed: How an ultrapowerful antioxidant works to prevent disease and promote health. Keats Publishing, Inc., New Caanan, CT.
23. Keys, A., Menotti, A., Karvonen, M.J., Aravanis, C., Blackburn, H., Buzina, R., Djordjevic, B.S., Dontas, A.S., Fidanza, F., Keys, M.H., et al (1986).: The diet and 15-year death rate in the Seven Countries Study. Amer. J. Epidemiol. 124: 903-915.
24. Lee, N.A. and Reasner, C.A. (1994).: Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17: 1449-1452.
25. Lefavi, R.G., Wilson, D., Keith, R.E., Anderson, R.A., Blessing, D.L., Hanes, C.G. and McMillan, J.L. (1993).: Lipid lowering effect of a dietary chromium (III)-nicotinic acid complex in male athletes. Nutr. Res. 13: 239-249.
26. Lichtenstein, A.H. (1996).: Atherosclerosis. In: Present Knowledge in Nutrition. 7th Edition. Edited by E.E. Ziegler and L.A. Filer, Jr. ILSI Press. Washington, DC. pp. 430-437.
27. Liebhaber, M.I., Wright, R.S., Gelberg, H.J., Dyer, Z. and Kupperman, J.L. (1999).: Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report often cases. Chest. 115: 886-889.
28. Mertz, W. (1993).: Chromium in Human Nutrition: A review. J. Nutr. 123: 626-633.
29. Mormando, R.M. (2000).: Lipid levels. Applying the second National Cholesterol Education Program report to geriatric medicine. Geriatrics 55: 48-53.
30. Newman, H.A., Leighton, R.F., Lanese, R.R. and Freedland, N.A. (1978).: Serum chromium and angiographically determined coronary artery disease. Clin. Chem. 24: 541-544.
31. Nuttall, S.L., Kendall, M.J., Bombardelli, E. and Morazzoni, P. (1998).: An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J. Clin. Pharm. Ther. 23: 385-389.
32. Offenbacher, E.G. and Pi-Sunyer, F. (1980).: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29: 919-925.
33. Offenbacher, E.G. and Pi-Sunyer, F.X. (1988).: Chromium in human nutrition. Ann. Rev. Nutr. 8: 543-563.
34. Pekkanen, J., Linn, S., Heiss, G., Suchindran, C.N., Leon, A., Rifkind, B.M. and Tyroler, H.A. (1990).: Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. New Engl. J. Med. 322: 1700-1707.
35. Press, R.I., Geller, J. and Evans, G.W. (1990).: The effects of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West, J. Med. 152: 41-45.
36. Preuss, H.G., Gondal, J.A., Bustos, E., Bushehri, N., Lieberman, S., Bryden, N.A., Polansky, M.M. and Anderson, R.A. (1995).: Effects of chromium and guar on sugar-induced hypertension in rats. Clin. Nephrol. 45: 170-177.
37. Preuss, H.G., Grojec, P.L., Lieberman, S. and Anderson, R.A. (1997).: Effects of different chromium compounds on blood pressure and lipid peroxidation in spontaneously hypertensive rats. Clin. Nephrol. 47: 325-330.
38. Rackley, C.E. (1996).: Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Clin. Cardiol. 19: 683-689.
39. Ray, S.D., Kumar, M. A. and Bagchi, D. (1999).: A novel proanthocyanidin IH636 grape seed extract increases in vivo bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver. Arch. Biochem. Biophys. 369: 42-58.
40. Ray, S.D., Parikh, H., Hickey, E., Bagchi, M. and Bagchi, D. (2000a).: Differential effects of IH636 grape seed proanthocyanidin extract and a DNA repair modulator 4-aminobenzamide on liver microsomal cytochrome P4502E1-dependent aniline hydroxylation. Mol. Cell. Biochem. (in press).
41. Ray, S.D., Parikh, H., Ali, S., and Bagchi, D. (2000b).: IH636 Grape seed proanthocyanidin extract (GSPE) exposure significantly attenuates dimethylnitrosamine (DMN)-induced liver cancer and mortality in ICR mice. Proc. Amer. Assoc. Cancer Res. 41: 460.
42. Ray, S.D., Patel, D., Wong, V. and Bagchi, D. (2000c). In Vivo protection of DNA damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract Res. Commun. Molec. Pathol. Pharmacol. 107: 137-166.
43. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P. and Hennekens, C.H. (1997).: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Engl. J. Med. 336: 973-979.
44. Rifici, V.A., Stephan, E.M., Schneider, S.H. and Khachadurian, A.K, (1999).: Red wine inhibits the cell-mediated oxidation of LDL and HDL. J. Amer. Coll. Nutr. 18: 137-143.
45. Roeback, Jr., J.R., Hla, K.M., Chambless, L.E. and Fletcher, R.H. (1991).: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta blocker. Ann. Intern. Med. 115: 917-924.
46. Sato, M., Maulik, G., Ray, P.S., Bagchi, D. and Das, D.K. (1999).: Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J. Mol. Cell. Cardiol. 31: 1289-1297.
47. Schroeder, H.A., Nason, A.P. and Tipton, I.H. (1970).: Chromium deficiency as a factor in atherosclerosis. J. Chron. Dis. 23: 123-142.
48. Shekelle, R.B., Shryock, A.M., Paul, O., Lepper, M., Stamler, J., Liu, S. and Raynor, Jr., W.J. (1981).: Diet, serum cholesterol, and death from coronary heart disease: The Western Electric Study. New Engl. J. Med. 304: 65-70.
49. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., Macfarlane, P.W., McKillop, J.H. and Packard, C.J. (1995).: Prevention of coronary heart disease with Pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New Engl. J. Med. 333: 1301-1307.
50. Simonoff, M. (1984).: Chromium deficiency and cardiovascular risk. Cardiovas. Res. 18: 591-596.
51. Simonoff, M., Llabador, Y., Hamon, C., Peers, A.M. and Simonoff, G.N. (1984).: Low plasma chromium in patients with coronary artery and heart diseases. Biol. Trace Elem. Res. 6: 431-439.
52. Tyson, D.A., Talpur, N.A., Echard, B.W., Bagchi, D. and Preuss, H.G. (2000).: Acute effects of grape seed extract and niacin-bound chromium on cardiovascular parameters of normotensive and hypertensive rats. Res. Comm. Pharmacol. Toxicol. 5: 91-106.
53. Urberg, M., Benyi, J. and John, R. (1988).: Hypocholesterolemic effects of nicotinic acid and chromium supplementation. The J. Family Prac. 27: 603-606.
54. Uusitupa, M.I., Mykkanen, L., Siitonen, O., Laakso, M., Sarlund, H., Kolehmainen, P., Rasanen, T., Kumpulainen, J. and Pyorala, K. (1992).: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide, and lipid levels. Brit. J. Nutr. 68: 209-216.
55. Yamakoshi, J., Kataoka, S., Koga, T. and Ariga, T. (1999).: Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142: 139-149.
56. Ye, X., Krohn R.L., Liu W., Joshi, S.S., Kuszynski, C.A., McGinn, T.R., Bagchi, M., Preuss, H.G., Stohs, S.J. and Bagchi, D. (1999).: The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol. Cell. Biochem. 196: 99-108.